- Home
- PDSB
PDSB
PDS Biotechnology Corporation
as 07-26-2024 4:00pm EST
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | PRINCETON |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | $16.67 | AVG Volume (30 days): | 691.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.37 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.53 - $6.85 | Next Earning Date: | 08-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest PDS Biotechnology Corporation News
PDSB Breaking Stock News: Dive into PDSB Ticker-Specific Updates for Smart Investing
MT Newswires
a month ago
B. Riley Lowers Price Target on PDS Biotechnology to $9 From $11, Maintains Buy Rating
GlobeNewswire
a month ago
PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in Head and Neck Cancer
Associated Press Finance
2 months ago
PDS Biotechnology: Q1 Earnings Snapshot
GlobeNewswire
2 months ago
PDS Biotech Provides Business Update and Reports First Quarter 2024 Financial Results
MT Newswires
3 months ago
PDS Biotechnology Says Head, Neck Cancer Therapy Met Main Goal in Mid-Stage Study
GlobeNewswire
3 months ago
PDS Biotech VERSATILE-002 Phase 2 Clinical Trial Meets Primary Study Endpoints in First Line Recurrent/Metastatic HPV16-Positive Head and Neck Cancer
GlobeNewswire
3 months ago
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
GlobeNewswire
3 months ago
PDS Biotech to Announce First Quarter 2024 Financial Results on May 15, 2024
Compare PDSB vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PDSB PDS Biotechnology Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.